Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2026-01-20 @ 11:13 PM
Study NCT ID:
NCT00729950
Status:
COMPLETED
Last Update Posted:
2010-04-26
First Post:
2008-08-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07
Start Date Type:
None
Primary Completion Date:
2005-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-08-06
First Submit QC Date:
None
Study First Post Date:
2008-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-04-23
Last Update Post Date:
2010-04-26
Last Update Post Date Type:
ESTIMATED